Copyright
©The Author(s) 2020.
World J Gastroenterol. Jan 14, 2020; 26(2): 219-245
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.219
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.219
Ref. | Type of study/No. of patients recruited | Study group(s) | Plasma exchange regime | Etiology of liver failure | Results/outcome(s) of interest |
Larsen et al[3] | Open randomized control trial; | PE + SMT vs SMT | Plasma exchange volume: Volume of plasma exchange was 15% of ideal body weight (representing 8-12 L per day per procedure); patient plasma was removed at a rate of 1-2 L per hour with replacement with fresh frozen plasma in equivalent volume | Predominantly paracetamol (59%), followed by unknown etiology, toxic hepatitis, viral hepatitis, acute Budd Chiari syndrome | HVP increases transplant free survival after 3 mo, and maximal effect of HVP was achieved in patients who did not undergo emergency transplantation |
n = 182 (Plasma exchange + SMT 92, SMT 90) | |||||
Overall hospital survival was 58.7% for patients treated with high volume plasma exchange vs 47.8% for control group HR: 0.56 (95%CI: 0.36-0.86), P < 0.01 | |||||
However, HVP prior to transplantation did not improve survival compared with patients who received SMT alone P = 0.75 | |||||
HVP procedure was undertaken on three consecutive days but with no fixed time interval between each treatment | |||||
Bilirubin, INR, ALT and ammonia concentration decreased significantly during the first 7 d compared to SMT | |||||
Mean number of HVP = 2.4 ± 0.8 | |||||
Plasma exchange with donor plasma | |||||
Nakae et al[10] | Prospective cohort study; n = 13 | PE vs PE + CHDF | Plasma exchange volume: 3.6 to 4.0 L of plasma was exchanged for the same volume of normal FFP, interval between sessions was 48h or more for both treatment methods | 7 post surgery, 4 fulminant hepatitis, 4 sepsis | Total bilirubin levels were significantly lower after treatment in both arms: Both P < 0.01 in both groups |
No outcomes available on mortality | |||||
Of note, decreased increase in citrate in patients with PE CHDF compared to PE alone | |||||
Plasma exchange with FFP | |||||
Hung et al[5] | Retrospective cohort study; n = 62 (Control 32, PE 30) | PE vs control | Average plasma exchange volume: 2916 mL (range, 1875-3750 mL), plasma exchange occurred over 2 h | 46.7% HBV, 33.3% Drug induced, 6.7% unknown, 33.3% cirrhosis. | At the end of the first week (week 1), the level of total bilirubin and grading of hepatic encephalopathy in the PE group were significantly lower than those in the control group. At the end of the second week (week 2), there were no differences in the level of total bilirubin and grading of hepatic encephalopathy between the two groups of patients |
Difference in survival rate was not significant 66.7% in PE group vs 59.4% in control group | |||||
No significant differences in etiology of liver failure between treatment and control groups | |||||
Average of 6 rounds of exchange per patient (range, 2-15 rounds) | |||||
Difference in survival days were significant, with 17.63 ± 1.86 in PE group vs 8.69 ± 0.86 in control group. P = 0.01 | |||||
Plasma exchange with FFP | |||||
Li et al[4] | Retrospective cohort study; n = 61 | PE + HP + CVVHDF, PE + CVVHDF and HP + CVVHDF | Plasma exchange volume: 2000-3000 mL of fresh per session. Flow rate was 80-120 mL/min, the plasma separation rate was 25-30 mL/min, the replacement time was 2.0-3.0 h | 3/61 acute viral hepatitis, 17/61 chronic toxic acute liver failure. 41 cases of non-viral induced liver injury: 5 after cardiac surgery, 7 with drug poisoning, 13 cases after pregnancy childbirth, 1 case mushroom poisoning, 10 cases with severe infection, 5 others | Treatment of the 61 patients using the artificial liver support system yielded a survival rate of 62.3% (38/61), and a viral survival rate of 35.0% (7/20); with the non-viral survival rate being 75.6% (31/41) Biochemically PE + HP + CVVHDF and PE + CVVHDF groups saw improvement in total bilirubin, ALT, PT, Albumin and HP+CVVHDF saw improvement in total and ALT (P < 0.05) |
In the PE + HP + CVVHDF group: After completion of a single plasma exchange, the HP was carried out. After HP, the CVVHDF is carried out | |||||
Total of 171 exchanges were done | |||||
Nakamura et al[11] | Retrospective case series n = 49; Fulminant hepatitis 15; Severe acute hepatitis 14; Healthy controls 20 | No comparative arm | Plasma exchange volume: Approximately 2000–4000 mL of fresh-frozen plasma was substituted during each exchange | No mention | 10/15 fulminant hepatitis and all severe acute hepatitis survived |
Significant decreases in circulating TNF-a, IL-6, and TGF-ß levels in patients with fulminant hepatitis after a single plasma exchange | |||||
Plasma exchange with FFP | |||||
Akdogan et al[9] | Retrospective case series; n = 39 (fulminant hepatic failure) | PE, No comparative arm | Plasma exchange volume: Total plasma volume approximately 1 | Predominantly undetermined (41%), paracetamol (28.5%), acute hepatitis B, autoimmune liver disease, vascular tumor, acute hepatitis A (in presence of cirrhosis) | Improved biochemically (coagulopathy hyperbilirubinemia, AST, Ammonia, Factor V levels): P < 0.05 |
Plasma exchange continued on a daily basis till clinical response (subjective by ICU team) or patient expired, or transplanted | 31% underwent liver transplant, 92% of which survived at 1 year | ||||
Overall survival 54% (21/39 patients), 37% (10/27) of non-transplanted patients survived | |||||
No need for calcium replacement or magnesium replacement | |||||
Plasma exchange with low volume citrate plasma | |||||
Kondrup et al[6] | Case series; n = 11 | PE, No comparative arm | Plasma exchange volume: 20% body weight plasma exchange intended on three consecutive days, obtained a mean 2.6 exchanges and mean volume 16% body weight | 6 acetaminophen, 2 non-A/B hepatitis, Halothane, disulfurum toxicity and hepatitis B | 5/11 survivors were all acetaminophen toxicity induced ALF |
All had improved bilirubin after treatment | |||||
All 4 Grade IV encephalopathy patients all did not survive | |||||
Plasma exchange with donor plasma. | Those that survived had Grade III encephalopathy or lesser | ||||
Those that did not survive had a longer duration of coma before initiation of PE (3.5 vs 1.8 d) | |||||
Freeman et al[13] | Case series | PE, No comparative arm | Plasma exchange volume: 3 L of plasma exchange was performed daily until conscious level improved or patient died Plasma exchange fluid: Equal volume of compatible fresh frozen plasma and plasma protein fraction (PPF) usually in the proportion of 2 units FFP:1 PPF | 4 acetaminophen, 2 nonA/B hepatitis, 1 hepatitis A, 1 mixed drug overdose, 1 ETOH in 2 | 7/9 showed improvement in coma grades, 5 achieved normal mental state, 5 were able to discharge from hospital. Of which 3 were paracetamol induced liver failure, 1 was monoamine oxidase/ tricyclic acid induced, 1 was alcohol. Survival 55% |
n = 9 | |||||
Improved biochemistry, bilirubin, coagulation (P < 0.01) 1 died of retroperitoneal bleeding | |||||
Buckner et al[7] | Case series | PE, No comparative arm | Plasma exchange volume: Initial 10 L/day plasma exchange with FFP or fresh/outdated plasma | 1 Acute viral hepatitis (pediatric), 2 halothane, 1 hepatitis B viral hepatitis | 1 died (pediatric) |
1 patient took 37 d to awake from coma | |||||
n = 4 (1 pediatric) | |||||
3/4 of patients survived | |||||
Liu et al[31] | Case series | PE, No comparative arm | Plasma exchange volume: Each treatment lasted for 4-6 h, and the total volume exchanged was approximately 7000 mL (1.5-2x TPV) | DILI | The two patients with DILI ALF were treated with PE without need for transplant |
n = 2 | |||||
Biochemically improved after PE (AST ALT Bilirubin) | |||||
Plasma exchange fluid: Maximally, 4700 mL of FFP was exchanged in each session, and the rest comprised plasma substitute consisting of 25% human albumin, pentastarch, 0.9% saline, and Ringer's solution. In each session, the plasma substitute was exchanged initially, and FFP was exchanged at the end | |||||
Duration of PE was based on clinical improvement, both patients had intermittent PE, total 3 sessions | |||||
Bilgir et al[15] | Case report | PE, No comparative arm | Plasma exchange volume: Each session consists of 15 units of FFP, total 4 sessions | L-asparaginase induced ALF | Patient recovered from ALF: However, no biopsy done |
Plasma exchange fluid: FFP | |||||
Aydemir et al[14] | Case report | PE, No comparative arm | Plasma exchange volume: 2500 mL plasma volume removed during each PE session | PTU induced ALF | Patient recovered from ALF: however, no biopsy done |
Plasma exchange fluid: Fresh frozen plasma | |||||
Riveiro-Barciela et al[28] | Letter to editor, case report (Ipilimumab) | PE, No comparative arm | Plasma exchange volume: 1500 mL of 5% albumin plus 4 units of plasma as replacement fluid, carried out every other day for total 5 treatments | Immunotherapy induced ALF | Patient improved. Liver tests within normal values within one month |
Plasma exchange fluid: FFP and 5% albumin | |||||
Damsgaard et al[8] | Case report (ALF in WD) | PE, No comparative arm | Plasma exchange volume: 8-9 L of plasma, total 12 HVP | Fulminant Wilson’s disease ALF | Even though WD ALF score was 16, patient survived without need for OLT |
Plasma exchange fluid: Fresh frozen plasma as replacement fluid 1:1 | |||||
Göpel et al[33] | Case report (Letter to editor) | PE, No comparative arm | Plasma exchange treatment was performed for three consecutive days | Peg-asparaginase induced ALF | Patient improved. Continuous stabilization of fibrinogen and antithrombin 3, an increase of cholinesterase, and a decrease of bilirubin. Clinical signs and symptoms such as jaundice and ascites did also rapidly improve |
No mention of volume or type of exchange fluid | |||||
Lin et al[16] | Case report | PE, no comparative arm | Plasma exchange was performed 2 times per week, and 2000 to 2500 mL frozen plasma was used each time | HLH | Patient’s condition deteriorated, and he died of multi-organ failure during the 6th week of hospitalization. Autopsy was declined |
Chen et al[29] | Case report | PE, No comparative arm | Plasma exchange volume: Estimated two times the plasma volume of the patient was exchanged. At most, 40 units of FFP were exchanged, with the remainder of the infused volume consisting of plasma substitutes. The plasma substitutes consisted of 25% human albumin, pentastarch, normal saline, and Ringer’s solution | Heat stroke | On day 4 after the admission, the patient received high-volume PE (two plasma volumes exchanged). His consciousness was improved a day after PE The patient was discharged on day 16 after admission without sequelae |
Holt et al[17] | Case report | PE, No comparative arm | Plasma exchange on post-partum days 3-5. Volume: Average of 3.2 L (1.6 estimated plasma volumes) of FFP replaced per session, followed by a tapering course of prednisone | AFLP vs HSV hepatitis associated ALF | After 3 d of TPE the patient’s mental status had returned to normal |
Treatment with TPE was followed by biochemical and clinical improvement but during her recovery herpes simplex virus type 2 (HSV‐2) infection was diagnosed serologically and confirmed histologically | |||||
Shen et al[18] | Case report | PE, No comparative arm | Plasma exchange: performed on days 1, 3, and 5, with 3000 mL of plasma exchanged during each session | Occupational Exposure to Tetrachloroethylene | Bilirubin, ammonia, and prothrombin time improved before hospital discharge and patients mental status gradually became normal discharged on day 26 of hospital admission |
Pashaei et al[30] | Case report | PE, No comparative arm | Plasma exchange volume 2.5L | Wilson’s disease | 36 h after initiation of PE, encephalopathy recovered and there was no renal impairment. Copper, LDH total bilirubin decreased after the treatment |
Plasma exchange fluid: FFP |
- Citation: Tan EXX, Wang MX, Pang J, Lee GH. Plasma exchange in patients with acute and acute-on-chronic liver failure: A systematic review. World J Gastroenterol 2020; 26(2): 219-245
- URL: https://www.wjgnet.com/1007-9327/full/v26/i2/219.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i2.219